Partners

Fresenius Kabi is a global healthcare company, which specializes in clinical nutrition, fluid therapy, intravenous drugs, infusion and transfusion technology. The products and services offered by Fresenius Kabi enable provide comprehensive care for critically and chronically ill patients.Every day, more than 37,000 Fresenius Kabi employees care for the health and lives of patients around the world. High quality products are manufactured at 70 production facilities in Europe, North America, Latin America, Asia and Africa. FRESENIUS KABI IN POLAND Fresenius Kabi Polska Sp. z o.o. has been present on the Polish market since 1999. It is a part of the international pharmaceutical Fresenius AG pharmaceutical corporation with its headquarters in Bad Homburg in Germany.

Fresenius Medical Care is the world's largest provider of products and services for people with chronic renal failure. The company's global network of over 4,000 dialysis centers treats over 344,000 patients. At the same time, the company operates 44 production plants on all continents, offering dialysis services and products in over 150 countries. In addition to a network of its own dialysis stations and the supply of equipment and a full range of consumables for hemodialysis and peritoneal dialysis, Fresenius Medical Care is also a leading supplier of therapeutic systems for acute patients covering a wide range of extracorporeal therapies from CRRT to ECMO. Fresenius Medical Care Polska S.A. was established in 2001 in Poznań, when an international concern took over its existing distributor - a company that had been equipping nephrology centers with Fresenius products for many years. Since then, Fresenius Medical Care has been invariably one of the most important suppliers of medical equipment in Poland.

As a leading global medical technology and digital solutions innovator, GE Healthcare enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform. With over 100 years of healthcare industry experience and around 50,000 employees globally, the company operates at the center of an ecosystem working toward precision health, digitizing healthcare, helping drive productivity and improve outcomes for patients, providers, health systems and researchers around the world. More.

For more than 50 years, Fisher & Paykel Healthcare (F&P) has been a leading designer and manufacturer of medical devices and products used in respiratory therapy, acute care, surgery and obstructive sleep apnea treatment. F&P has supported Poland for over 30 years, and in 2019 a direct team was formed to provide specialized product and clinical support to physicians across the country. During the COVID-19 pandemic, our Airvo 2 Optiflow system was the most widely used high-flow intranasal therapy system nationwide (as well as in many countries around the world) and continues to be used to support patients with respiratory failure. Our medical devices and technologies enable patients to transfer out of the acute care unit more quickly, recover more quickly, and avoid more serious outcomes. Product innovation has been at the heart of our success since we developed our first respiratory humidifier in 1969. Today, we continue to strive to be a leader in medical device and technology development by continually improving our products, introducing new therapies and changing clinical practice.

At Medtronic, we believe in the power of medical technology to improve lives. Seven decades ago, our co-founder invented the battery-powered pacemaker. Today, we are among the largest medical device companies in the world. With operations in 150 countries, our products treat 70 health conditions and include cardiac devices, cranial and spine robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Our therapies help 72 million people a year and support our Mission to alleviate pain, restore health, and extend life.

CytoSorbents is a leader in critical care immunotherapy, specializing in blood purification. Its flagship product CytoSorb® is a CE approved extracorporeal cytokine adsorber, designed to broadly reduce cytokine storm and other inflammatory mediators in the blood that could otherwise lead to uncontrolled systemic inflammation, organ failure, and death in many life-threatening illnesses. CytoSorb has been used safely in more than 131,000 treatments worldwide, primarily in the treatment of systemic hyperinflammation in a wide variety of life-threatening conditions. CytoSorb® is distributed in over 60 countries around the world. For more information visit www.cytosorb.com

Edwards

Edwards Lifesciences is the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. Driven by a passion to help patients, the company collaborates with the world’s leading clinicians and researchers to address unmet healthcare needs, working to improve patient outcomes and enhance lives.